Eton Pharmaceuticals, Inc. - Common Stock (ETON)

42 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.43M shares of 26.8M outstanding shares and own 20.23% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.39M shares), VANGUARD GROUP INC (878K shares), AWM Investment Company, Inc. (500K shares), Roumell Asset Management, LLC (449K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (203K shares), GEODE CAPITAL MANAGEMENT, LLC (176K shares), Westside Investment Management, Inc. (119K shares), MARSHALL WACE, LLP (92.1K shares), PARADIGM CAPITAL MANAGEMENT INC/NY (90K shares), and STATE STREET CORP (83.8K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.